

Nel ASA reported Q2 2026 customer contract revenues of NOK 153M, down 12% YoY (but up NOK 5M QoQ). Total revenue and income rose to NOK 182M from NOK 152M in Q1, but EBITDA was NOK -155M versus NOK -100M in Q1, with a NOK 70M negative impact from the Iwatani settlement. Order intake data is cut off in the provided text, but the earnings/EBITDA deterioration points to near-term pressure despite QoQ revenue improvement.
The important read-through is not the quarterly loss itself; it is that the core business is still not generating enough operating leverage to absorb fixed manufacturing and overhead costs. Once you strip out the settlement, the burn profile still looks inconsistent with a self-funding industrial ramp, which raises the probability that any equity value support will keep depending on sentiment and policy headlines rather than bookings conversion.
For competitors, this is broadly negative for the listed hydrogen equipment complex, especially names like PLUG and the HJEN ETF, because weak conversion at a known brand reinforces the market’s suspicion that electrolyzer demand remains lumpy and subsidy-dependent. Second-order, customers and project developers are likely to delay final investment decisions until they see clearer backlog quality and financing availability, which pushes revenue recognition farther out and keeps pricing pressure high across the supply chain.
The next 1-3 months matter more than the reported quarter: the key catalyst is whether order intake and backlog can show genuine acceleration, not just stabilization. If not, the market will start pricing in dilution risk or a slower path to breakeven within 6-18 months. The contrarian point is that this could be less about structural demand destruction and more about timing; if a large tender cycle or subsidy award lands, the stock can rerate sharply because expectations are already low. What would falsify the bearish view is a clear order-book inflection and a materially smaller adjusted EBITDA loss next quarter.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment